Jump to ContentJump to Main Navigation

Translational Neuroscience

1 Issue per year


IMPACT FACTOR increased in 2013: 0.716

SCImago Journal Rank (SJR): 0.361
Source Normalized Impact per Paper (SNIP): 0.170

Open Access
VolumeIssuePage

Serial changes in plasma homocysteine in acute clinical stroke

1Department of Physiology, Shaikh Zayed Federal Postgraduate Medical Institute (SZFPGMI), University of Health Sciences, Lahore, Pakistan

2Department of Medicine Unit-4, Services Institute of Medical Sciences (SIMS), Lahore, Pakistan

3Department of Neurology, Shaikh Zayed Hospital, Lahore, Pakistan

4National Health Research Complex (NHRC), Lahore, Pakistan

© 2012 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. (CC BY-NC-ND 3.0)

Citation Information: Translational Neuroscience. Volume 3, Issue 1, Pages 41–45, ISSN (Online) 2081-6936, ISSN (Print) 2081-3856, DOI: 10.2478/s13380-012-0005-1, March 2012

Publication History

Published Online:
2012-03-14

Abstract

Keywords: Plasma homocysteine; Serial samples; Ischemic stroke; Haemorrhagic stroke; Stroke

  • [1] Hankey G. J., Stroke: how large a public health problem, and how can the neurologist help? Arch. Neurol., 1999, 56, 748–754 http://dx.doi.org/10.1001/archneur.56.6.748 [CrossRef]

  • [2] Kim A. S., Johnston S.C., Global variation in the relative burden of stroke and ischemic heart disease, Circulation, 2011, 124, 314–323 http://dx.doi.org/10.1161/CIRCULATIONAHA.111.018820 [CrossRef]

  • [3] Mattson M. P., Shea T. B., Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders, Trends Neurosci., 2003, 26, 137–146 http://dx.doi.org/10.1016/S0166-2236(03)00032-8 [CrossRef]

  • [4] Zou C. G., Banerjee R., Homocysteine and redox signaling, Antioxid. Redox Signal., 2005, 7, 547–559 http://dx.doi.org/10.1089/ars.2005.7.547 [CrossRef]

  • [5] Schroecksnadel K., Frick B., Winkler C., Leblhuber F., Wirleitner B., Fuchs D., Hyperhomocysteinemia and immune activation, Clin. Chem. Lab. Med., 2003, 41, 1438–1443 http://dx.doi.org/10.1515/CCLM.2003.221 [CrossRef]

  • [6] Alfthan G., Pekkanen J., Jauhiainen M., Pitkäniemi J., Karvonen M., Tuomilehto J. et al., Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study, Atherosclerosis, 1994, 106, 9–19 http://dx.doi.org/10.1016/0021-9150(94)90078-7 [CrossRef]

  • [7] Howard V. J., Sides E. G., Newman G. C., Cohen S. N., Howard G., Malinow M. R. et al., Changes in plasma homocyst(e)ine in the acute phase after stroke, Stroke, 2002, 33, 473–478 http://dx.doi.org/10.1161/hs0202.103069 [CrossRef]

  • [8] Karttunen V., Alfthan G., Hiltunen L., Rasi V., Kervinen K., Kesäniemi Y. A. et al., Risk factors for cryptogenic ischaemic stroke, Eur. J. Neurol., 2002, 9, 625–632 http://dx.doi.org/10.1046/j.1468-1331.2002.00464.x [CrossRef]

  • [9] Kristensen B., Malm J., Nilsson T.K., Hultdin J., Carlberg B., Dahlén G. et al., Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke, Stroke, 1999, 30, 974–980 http://dx.doi.org/10.1161/01.STR.30.5.974 [CrossRef]

  • [10] Lindgren A., Brattström L., Norrving B., Hultberg B., Andersson A., Johansson B.B., Plasma homocysteine in the acute and convalescent phases after stroke, Stroke, 1995, 26, 795–800 http://dx.doi.org/10.1161/01.STR.26.5.795 [CrossRef]

  • [11] Meiklejohn D. J., Vickers M. A., Dijkhuisen R., Greaves M., Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke, Stroke, 2001, 32, 57–62 http://dx.doi.org/10.1161/01.STR.32.1.57 [CrossRef]

  • [12] Lonn E., Yusuf S., Arnold M.J., Sheridan P., Pogue J., Micks M. et al., Homocysteine lowering with folic acid and B vitamins in vascular disease, N. Engl. J. Med., 2006, 354, 1567–1577 http://dx.doi.org/10.1056/NEJMoa060900 [CrossRef]

  • [13] Bønaa K. H., Njølstad I., Ueland P. M., Schirmer H., Tverdal A., Steigen T. et al., Homocysteine lowering and cardiovascular events after acute myocardial infarction, N. Engl. J. Med., 2006, 354, 1578–1588 http://dx.doi.org/10.1056/NEJMoa055227 [CrossRef]

  • [14] Toole J. F., Malinow M. R., Chambless L. E., Spence J. D., Pettigrew L. C., Howard V. J. et al., Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial, JAMA, 2004, 291, 565–575 http://dx.doi.org/10.1001/jama.291.5.565 [CrossRef]

  • [15] National Institute for Health and Clinical Excellence, Clinical guideline on Stroke: Diagnosis and initial management of acute stroke and transient ischemic attack (TIA), NICE clinical guideline 68, London: National Institute for Health and Clinical Excellence, 2008

  • [16] Voortman A., Melse-Boonstra A., Schulz J. M., Burema J., Katan M. B., Verhoef P., Optimal time interval between repeated blood sampling for measurements of total homocysteine in healthy individuals, Clin. Chem., 2001, 47, 1839–1841

  • [17] Haapaniemi E., Helenius J., Soinne L., Syrjala M., Kaste M., Tatlisumak T., Serial measurements of plasma homocysteine levels in early and late phases of ischemic stroke, Eur. J. Neurol., 2007, 14, 12–17 http://dx.doi.org/10.1111/j.1468-1331.2006.01518.x [CrossRef] [Web of Science]

  • [18] Egerton W., Silberberg J., Crooks R., Ray C., Xie L., Dudman N., Serial measures of plasma homocyst(e)ine after acute myocardial infarction, Am. J. Cardiol., 1996, 77, 759–761 http://dx.doi.org/10.1016/S0002-9149(97)89213-2 [CrossRef]

  • [19] Sastry B. K., Indira N., Anand B., Kedarnath, Prabha B. S., Raju B. S., A case-control study of plasma homocysteine levels in South Indians with and without coronary artery disease, Indian Heart J., 2001, 53, 749–753

  • [20] Iqbal M. P., Ishaq M., Kazmi K. A., Yousuf F. A., Mehboobali N., Ali S. A. et al., Role of vitamins B6, B12 and folic acid on hyperhomocysteinemia in a Pakistani population of patients with acute myocardial infarction, Nutr. Metab. Cardiovasc. Dis., 2005, 15, 100–108 http://dx.doi.org/10.1016/j.numecd.2004.05.003 [CrossRef]

  • [21] Iqbal M. P., Fatima T., Parveen S., Yousuf F. A., Shafiq M., Mehboobali N. et al., Lack of association of methylenetetrahyclrofolate reductase 677C>T mutation with coronary artery disease in Pakistani population, J. Mol. Genet. Med., 2005, 1, 26–32

  • [22] Holmes M. V., Newcombe P., Hubacek J. A., Sofat R., Ricketts S. L., Cooper J. et al., Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials, Lancet, 2011, 378, 584–594 http://dx.doi.org/10.1016/S0140-6736(11)60872-6 [Web of Science] [CrossRef]

  • [23] Hultdin J., Van Guelpen B., Winkvist A., Hallmans G., Weinehall L., Stegmayr B. et al., Prospective study of first stroke in relation to plasma homocysteine and MTHFR 677C>T and 1298A>C genotypes and haplotypes — evidence for an association with hemorrhagic stroke, Clin. Chem. Lab. Med., 2011, 49, 1555–1562 http://dx.doi.org/10.1515/CCLM.2011.234 [CrossRef] [Web of Science]

  • [24] Somarajan B. I., Kalita J., Mittal B., Misra U. K., Evaluation of MTHFR C677T polymorphism in ischemic and hemorrhagic stroke patients. A case-control study in a Northern Indian population, J. Neurol. Sci., 2011, 304, 67–70 http://dx.doi.org/10.1016/j.jns.2011.02.010 [Web of Science] [CrossRef]

  • [25] Iso H., Moriyama Y., Sato S., Kitamura A., Tanigawa T., Yamagishi K. et al., Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese, Circulation, 2004, 109, 2766–2772 http://dx.doi.org/10.1161/01.CIR.0000131942.77635.2D [CrossRef]

  • [26] Li Z., Sun L., Zhang H., Liao Y., Wang D., Zhao B. et al., Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China, Stroke, 2003, 34, 2085–2090 http://dx.doi.org/10.1161/01.STR.0000086753.00555.0D [CrossRef]

Comments (0)

Please log in or register to comment.